Primary mediastinal large B-cell lymphoma with extensive cardiac involvement
Main Article Content
Abstract
Data regarding the optimal therapeutic approach of patients with primary mediastinal B-cell lymphoma and cardia c involvement are limited. Reports suggest that multi-agent systemic chemotherapy, along with radiation therapy, may be effective in the treatment of these patients. However, a subgroup of patients do die suddenly due to myocardial rupture following the initiation of treatment. We report on the successful management of a patient with primary mediastinal large B-cell lymphoma with extensive cardiac involvement.
Downloads
Article Details
Copyright (c) 2019 Pulido AL, et al.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Savage KJ, Monti S, Kutok JL, Cattoretti G, Neuberg D, et al. (2003) The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin’s lymphoma. Blood 102: 3871-3890. Link: http://bit.ly/32NQ9CP
Dunleavy K, Wilson WH (2015) Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach? Blood 125: 33-39. Link: http://bit.ly/2BG1Q2r
Wang ZJ, Reddy GP, Gotway MB, Yeh BM, Hetts SW, et al. (2003) CT and MR imaging of pericardial disease. Radiographics 23: S167-S180. Link: http://bit.ly/368sQp6
Nguyen JD, Carrasquillo JA, Little RF, Ryan QC, Wilson W, et al. (2003) Fluorodeoxyglucose positron emission tomography in the presence of cardiac metastases. Clin Nucl Med 28: 979-980. Link: http://bit.ly/347QgsP